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Abstract 
Background: Breast reconstruction after mastectomy is an integral part of breast cancer treatment that positively 
impacts quality of life in breast cancer survivors. Although breast reconstruction rates have increased over time, 
African American women remain less likely to receive breast reconstruction compared to Caucasian women. National 
Cancer Institute-designated Comprehensive Cancer Centers, specialized institutions with more standardized mod-
els of cancer treatment, report higher breast reconstruction rates than primary healthcare facilities. Whether breast 
reconstruction disparities are reduced for women treated at comprehensive cancer centers is unclear. The purpose of 
this study was to further investigate breast reconstruction rates and determinants at a comprehensive cancer center 
in St. Louis, Missouri.
Methods: Sociodemographic and clinical data were obtained for women who received mastectomy for definitive 
surgical treatment for breast cancer between 2000 and 2012. Logistic regression was used to identify factors associ-
ated with the receipt of breast reconstruction.
Results: We found a breast reconstruction rate of 54 % for the study sample. Women who were aged 55 and older, 
had public insurance, received unilateral mastectomy, and received adjuvant radiation therapy were significantly less 
likely to receive breast reconstruction. African American women were 30 % less likely to receive breast reconstruction 
than Caucasian women.
Conclusion: These findings suggest that racial disparities in breast reconstruction persist in comprehensive cancer 
centers. Future research should further delineate the determinants of breast reconstruction disparities across various 
types of healthcare institutions. Only then can we develop interventions to ensure all eligible women have access to 
breast reconstruction and the improved quality of life it affords breast cancer survivors.
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Background
Breast reconstruction after mastectomy has become 
an important component of the breast cancer care con-
tinuum for patients who receive mastectomy (Alder-
man et  al. 2009; Jagsi et  al. 2014; Tseng et  al. 2010), in 
part because of its positive effects on psychosocial func-
tioning and quality of life. Breast cancer patients who 
undergo reconstruction experience less distress, bet-
ter body image, better sexual function, and higher self-
esteem than those who do not undergo reconstruction 
(Al-Ghazal et al. 2000; Atisha et al. 2008; Harcourt et al. 
2003; Rowland et  al. 1993; Wilkins et  al. 2000). These 
women also report better physical functioning and less 
pain (Eltahir et  al. 2013). Thus, the long-term benefits 
that breast reconstruction affords, suggests that equitable 
access to this procedure optimizes breast cancer survi-
vorship (Alderman et al. 2009).
Although breast reconstruction rates have increased 
over time, they remain relatively low, ranging from 5 to 
42  % in population-based and institution-based studies 
(Brennan and Spillane 2013; Platt et  al. 2011; Wilkins 
and Alderman 2004). These studies have found that 
reconstruction rates are significantly lower in African 
American compared to Caucasian women (Alderman 
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et  al. 2009, 2011; Butler et  al. 2015; Greenberg et  al. 
2008; Hershman et al. 2012; Katz et al. 2005; Merchant 
et al. 2015; Morrow et al. 2005; Reuben et al. 2009; Ros-
son et  al. 2008; Rowland et  al. 2000; Tseng et  al. 2004; 
Yang et  al. 2013a, b), a disparity that has been attrib-
uted to racial differences in access to breast reconstruc-
tive services (Agarwal et  al. 2011; Enewold et  al. 2014; 
Greenberg et  al. 2008; Katz et  al. 2005; Offodile et  al. 
2015; Rowland et  al. 1993; Wexelman et  al. 2014) sec-
ondary to lower socioeconomic status (Alderman et  al. 
2003; Greenberg et al. 2008; Joslyn 2005; Katz et al. 2005; 
Kruper et al. 2011a; Offodile et al. 2015; Wexelman et al. 
2014) and no or inadequate insurance (Alderman et  al. 
2006; Bradley et al. 2012; Enewold et al. 2014; Wexelman 
et al. 2014).
National Cancer Institute-designated Comprehensive 
Cancer Centers (NCI-CCCs) are tertiary, specialized 
cancer centers that have higher breast reconstruction 
rates than those reported by primary healthcare insti-
tutions and population-based reports (Brennan and 
Spillane 2013). This may be because of the more stand-
ardized infrastructures imposed by NCI oversight, 
increased financial resources, higher numbers of recon-
structive surgeons focused on breast cancer care, or 
because surgeons at these institutions are somehow 
more aware of the psychological impact of breast recon-
struction (Greenberg et  al. 2011; Reuben et  al. 2009). 
The latter may be due to the cross-disciplinary nature of 
NCI-CCCs.
It is unclear whether racial disparities in breast recon-
struction are reduced in women treated for breast cancer 
at NCI-CCCs compared to other healthcare institutions, 
which one would expect if access to care was the sole 
or most salient issue. Yet, few studies have focused on 
determinants of breast reconstruction within NCI-CCCs 
(Christian et al. 2006; Elmore et al. 2012; Greenberg et al. 
2011; Sharma et al. 2015; Tseng et al. 2004). It is impor-
tant to examine breast reconstruction in different types 
of healthcare institutions to gain a better understanding 
of the determinants across health care settings (Iskandar 
et al. 2015). Understanding characteristics that are asso-
ciated with the receipt of high quality breast cancer care, 
such as that reported for NCI-CCCs, are essential for 
identifying and implementing the best practices needed 
to ensure equitable access to breast reconstruction for all 
women (Onega et al. 2014). Previous studies at Siteman 
Cancer Center focused on specific patient groups and 
utilized smaller sample sizes (Connors et al. 2014; Elmore 
et al. 2012; Sharma et al. 2015). The purpose of this study 
was to utilize a large multi-year sample to conduct a com-
prehensive examination of the rate and determinants of 
breast reconstruction at Siteman Cancer Center, a NCI-
CCC located in Saint Louis, Missouri.
Methods
Data source
Siteman Cancer Center is affiliated with the Wash-
ington University in St. Louis School of Medicine and 
BJC HealthCare of St. Louis, a 12-hospital system. We 
obtained de-identified data for women who received 
mastectomy for definitive surgical treatment for breast 
cancer at Siteman Cancer Center between 2000 and 
2012. Data were obtained from the Barnes-Jewish Hospi-
tal (BJH) Cancer Registry that is maintained by Oncology 
Data Services (ODS). The Human Research Protection 
Office (HRPO) and Institutional Review Board (IRB) 
at Washington University in St. Louis gave this study 
exempt status.
Data were obtained for 5421 women. The percentage 
of women of Asian descent was small (n =  120), there-
fore, we excluded these women from analysis. We also 
excluded 1147 women who received partial or segmental 
mastectomies, which are often lumpectomies that rarely 
receive breast reconstruction. The 1147 women excluded 
accounted for 1  % of the reconstruction in the origi-
nal sample. The final sample consisted of 4154 African 
American and Caucasian women who received mastec-
tomy for definitive breast cancer treatment.
Independent variables
Sociodemographic variables obtained from the BJC Can-
cer Registry included age at diagnosis, race, and type of 
insurance. Age was dichotomized as ≤55 and >55 years 
and three race categories were present in the Registry, 
African American, Asian, and Caucasian. Type of insur-
ance was categorized as public (Medicaid, Medicare, 
Veterans’ Affairs, Indian Health Service) or private [man-
aged care, Health Maintenance Organization (HMO), 
Preferred Provider Organization (PPO), TRICARE, and 
fee for service]. Clinical variables analyzed included lat-
erality of the breast tumor (right, left), tumor stage (stage 
0/ductal carcinoma in  situ (DCIS)-2, stage 3–4), tumor 
grade (grade 1–2, grade 3–4), estrogen receptor (ER) sta-
tus (positive, negative), progesterone receptor (PR) sta-
tus (positive, negative), human epidermal growth factor 
receptor 2 (HER2) status (positive, negative), triple nega-
tive status (no, yes). Triple negative status was only deter-
mined in women with expression results for ER, PR, and 
HER2.
Variables related to breast cancer treatment included 
type of mastectomy [total/simple, modified radical, radi-
cal/extended radical, skin/nipple-sparing, mastectomy 
not otherwise specified (NOS)], laterality of the mas-
tectomy (unilateral, bilateral), receipt of adjuvant radia-
tion (yes, no), receipt of adjuvant chemotherapy (yes, 
no), receipt of adjuvant hormonal therapy (yes, no), 
and receipt of breast reconstruction (yes, no). We also 
Page 3 of 9Connors et al. SpringerPlus  (2016) 5:955 
assessed the type of breast reconstruction (tissue expand-
ers/implants, autologous flap, autologous flap and tissue 
expanders/implants, reduction mammoplasty, scar revi-
sion (Y-plasty), reconstruction NOS. The placement of 
tissue expanders was considered implant-based recon-
struction. The primary outcome of interest was receipt of 
breast reconstruction of the diseased breast after defini-
tive mastectomy for breast cancer treatment.
Statistical analysis
We first summarized each variable as follows: continuous 
variables were described by mean and standard devia-
tion and categorical variables were summarized using 
frequencies and percentages. Independent variables that 
were significantly associated (p < 0.05) with the receipt of 
breast reconstruction in Chi squared analysis were exam-
ined in unadjusted logistic regression models. Variables 
with p values <0.1 in the unadjusted models were incor-
porated into the final multivariable logistic regression 
model. Adjusted odds ratios, 95  % confidence intervals, 
and p values were reported for regression analysis. All 
analysis was performed with Stata SE Version 12 (College 
Station, TX, USA), statistical significance was assessed as 
a p value <0.05.
Results
Sociodemographic and clinical characteristics are dis-
played in Table  1. The mean age of women in the sam-
ple was 55  years old. The majority of women (80  %, 
n =  3332) were Caucasian. Over half (58  %, n =  1975) 
of the women in the sample had private insurance, while 
42 % (n = 1454) had public insurance. Most women pre-
sented with tumors that were stage 0/DCIS, 1, or 2 (81 %, 
n = 3019) and grade 1 or 2 (59 %, n = 2314). Hormone 
receptor expression was also favorable; approximately 
74 % (n = 2706) and 64 % (n = 2316) of the sample pre-
sented with ER positive or PR positive tumors, respec-
tively. Twenty percent (n = 206) of the women presented 
with HER2 positive tumors and 12 % (n = 128) presented 
with triple negative tumors. Nearly 80  % (n =  3243) of 
the sample received unilateral mastectomy as definitive 
breast cancer surgery. The most common type of mastec-
tomy was total/simple mastectomy (52 %, n = 2148), fol-
lowed by modified radical mastectomy (40 %, n = 1636). 
Six percent (n = 267) of the sample received skin-sparing 
or nipple-sparing mastectomies. Less than half of the 
women (46 %, n = 1876) received adjuvant chemotherapy 
and 31 % (n = 1300) received adjuvant radiation. Approx-
imately half of the women (53  %, n  =  2164) received 
adjuvant hormonal therapy.
The breast reconstruction rate and types of reconstruc-
tive surgery are displayed in Table  2. The breast recon-
struction rate of this sample was 54 % (n = 2227). Over 
half of the women (n = 990) received placement of a tis-
sue expander/implant for reconstruction. Women also 
underwent reconstruction NOS (39 %, n = 762), autolo-
gous flap (7 %, n = 144), and combined autologous flap 
and placement of a tissue expander/implant for recon-
struction (2 %, n = 32). Reduction mammoplasty (0.2 %, 
n =  3) and scar revision (Y-plasty) (0.5  %, n =  9) were 
performed in <1 % of women.
The results of the multivariable logistic regression are 
displayed in Table 3. In adjusted analysis, the sociodemo-
graphic factors that significantly predicted breast recon-
struction were age, type of insurance, and race. Women 
aged 55 years or older where 65 % less likely (aOR 0.35; 
95  % CI 0.29–0.42, p  <  0.01) to receive breast recon-
struction than women under the age of 55. Women with 
public insurance were 55  % less likely (aOR 0.45, 95  % 
CI 0.38–0.54, p  <  0.01) to receive breast reconstruction 
than women who had private insurance. African Ameri-
can women were 30  % less likely (aOR 0.70, 95  % CI 
0.56–0.87, p < 0.01) to receive breast reconstruction than 
Caucasian women. 
Tumor stage was significantly associated the receipt 
of breast reconstruction in this sample. Women with 
stage 3–stage 4 tumors were 40 % less likely (aOR 0.60, 
95 % CI 0.47–0.76, p < 0.01) to receive breast reconstruc-
tion compared to women with stage 0/DCIS–stage 2 
tumors. Treatment factors significantly associated with 
the receipt of breast reconstruction included laterality 
of definitive mastectomy and receipt of adjuvant radia-
tion therapy. Women who received unilateral mastec-
tomy were 63 % less likely (aOR 0.37, 95 % CI 0.30–0.46, 
p  <  0.01) to receive breast reconstruction than women 
who received bilateral mastectomy. Women who received 
adjuvant radiation therapy were 28  % less likely (aOR 
0.72; 95  % CI 0.59–0.89, p  =  <0.01) to receive breast 
reconstruction than women who did not receive adjuvant 
radiation therapy. PR status (aOR 0.87, 95  % CI 0.87–
1.03, p  =  0.12) and receipt of adjuvant chemotherapy 
(aOR 0.72, 95 % CI 0.59–0.89, p = 0.55) were not signifi-
cantly associated breast reconstruction in this sample.
Discussion
The breast reconstruction rate (54  %) in this sample is 
high compared to the rates in population-based stud-
ies, which range from 5 to 29 % (Platt et al. 2011; Wilkins 
and Alderman 2004), but is consistent with previously 
reported rates for this and other NCI-CCCs (Chris-
tian et al. 2006; Connors et al. 2014; Elmore et al. 2012; 
Greenberg et al. 2011; Mitchem et al. 2008; Tseng et al. 
2004). Most (52  %) women in this sample received 
implant-based reconstruction, which is consistent pre-
vious studies at Siteman Cancer Center (Connors et  al. 
2014; Elmore et al. 2012; Mitchem et al. 2008), reflecting 
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the national trend of increasing rates of implant-based 
breast reconstruction (Albornoz et  al. 2012, 2013; Jagsi 
et al. 2014). Less than 1 % of women received reduction 
mammoplasty or scar revision (Y-plasty).
Age is one of the most consistent predictors of receiving 
breast reconstruction (Platt et  al. 2011). Our results are 
consistent with previous studies that report older women 
are less likely to receive breast reconstruction (Agarwal 
et al. 2011; Alderman et al. 2003, 2009; Chen et al. 2009; 
Desch et al. 1999; Elmore et al. 2012; Giladi et al. 2015; 
Greenberg et  al. 2008; Hershman et  al. 2012; Iskandar 
et al. 2015; Jackson et al. 2008; Joslyn 2005; Kruper et al. 
2011b; Mahmoudi et al. 2015; Maly et al. 2009; Morrow 
et  al. 2001, 2005, 2014; Polednak 1999; Preminger et  al. 
2012; Reuben et  al. 2009; Rosson et  al. 2008; Shippee 
et  al. 2014; Tseng et  al. 2010; Yang et  al. 2013a). Stud-
ies suggest that older women may choose not to have 
breast reconstruction because they are less disturbed by 
the prospect of breast loss or more worried about surgi-
cal morbidity and complications (Alderman et  al. 2003; 
Morrow et al. 2005; Reaby et al. 1994; Wolfswinkel et al. 
2013). Similar to previous studies, women with public 
insurance were significantly less likely to receive breast 
reconstruction than those with private insurance (Alder-
man et al. 2009; Bradley et al. 2012; Christian et al. 2006; 
Kruper et  al. 2011a, b; Mahmoudi et  al. 2015; Morrow 
et al. 2014; Shippee et al. 2014; Yang et al. 2013a). Lack 
of access to facilities with qualified plastic surgeons and 
lower payer reimbursement for services may play a role 
in this relationship (Christian et  al. 2006; Kruper et  al. 
2011a; Preminger et  al. 2012). Additionally, for women 
with public insurance, lower socioeconomic status may 
serve as a barrier to breast reconstruction because these 
women must be more attuned to the out-of-pocket costs 
associated with the procedures, loss of days from work, 
cost of transportation, and costs of childcare (Katz et al. 
2005; Wilkins and Alderman 2004). Siteman Cancer 
Center has increased its efforts to inform women of avail-
able financial, social, and other support services to cir-
cumvent these barriers (Fayanju et  al. 2013). It is likely 
that other NCI-CCCs have done the same.
Table 1 Sociodemographic and  clinical factors of  women 
treated with mastectomy for breast cancer at the Siteman 
Cancer Center from 2000 to 2012
Variable Mean SD N
Sociodemographics
 Age at diagnosis 55 13 4154
Frequency % N
Race
 African American 822 20 4154
 Caucasian 3332 80
Age (years)
 <55 2018 49 4154
 ≥55 2136 51
Type of insurance
 Privatea 1975 58 3429
 Publicb 1454 42
Clinical factors
 Tumor stage
  Stage 0/DCIS–2 3019 81 3709
  Stage 3–4 690 19
 Tumor grade
  Grade 1–2 2314 59 3903
  Grade 3–4 1589 41
 ER status
  Positive 2706 74 3633
  Negative 927 26
 PR status
  Positive 2316 64 3619
  Negative 1303 36
 HER2 status
  Positive 206 20 1016
  Negative 810 79
 Triple negative cancer
  No 941 88 1069
  Yes 128 12
 Laterality of mastectomy
  Bilateral 903 22 4146
  Unilateral 3243 78
 Type of definitive mastectomy
  Total/simple 2148 52 4126
  Modified radical 1636 40
  Radical/extended modified 
radical
58 1
  Skin/nipple-sparing 267 6
  Mastectomy NOS 20 0.5
 Received adjuvant chemotherapy
  No 2233 54 4109
  Yes 1876 46
 Received adjuvant radiation
  No 2854 69 4154
  Yes 1300 31
Table 1 continued
Frequency % N
 Received adjuvant hormonal therapy
  No 1894 47 4058
  Yes 2164 53
DCIS ductal carcinoma in situ, ER estrogen receptor, PR progesterone receptor, 
HER2 human epidermal growth factor receptor 2, NOS not otherwise specified
a Private insurance included: managed care, HMO, PPO, TRICARE, fee for service
b Public insurance included: Medicaid, Medicare, Veterans’ Affairs, Indian Health 
Service
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Stage of disease is considered the most predictive clini-
cal factor of receiving breast reconstruction (Platt et  al. 
2011). In this sample, women with more advanced tumor 
stages were significantly less likely to receive breast 
reconstruction. Many studies report women with earlier 
stages are more likely to receive breast reconstruction 
(Agarwal et al. 2011; Alderman et al. 2003; Bradley et al. 
2012; Chen et  al. 2009; Christian et  al. 2006; Enewold 
et  al. 2014; Iskandar et  al. 2015; Joslyn 2005; Morrow 
et al. 2001, 2005; Polednak 1999, 2000; Tseng et al. 2004). 
Although higher stage of disease is not a contraindication 
for breast reconstruction, women and/or their physicians 
may prioritize adjuvant treatment above reconstructive 
procedures (Agarwal et  al. 2011; Alderman et  al. 2007). 
Tumor grade did not significantly predict breast recon-
struction in this or previous studies (Enewold et al. 2014; 
Tseng et al. 2010).
The type of breast cancer treatment received corre-
lates with the receipt breast reconstruction (Jagsi et  al. 
2014). Women who received unilateral mastectomy were 
significantly less likely to receive reconstruction. This 
finding is consistent with previous studies (Elmore et al. 
2012; Hershman et  al. 2012; Iskandar et  al. 2015; Jagsi 
et al. 2014; Joslyn 2005; Preminger et al. 2012; Tseng et al. 
2010). Women who have bilateral mastectomies are more 
likely to be referred to plastic surgeons for breast recon-
struction consultations (Preminger et al. 2012) and it has 
been suggested that women who are highly motivated 
to receive breast reconstruction may choose bilateral 
mastectomies, even when it is not clinically indicated, 
to achieve better symmetry after reconstruction (Tseng 
et  al. 2010). Receipt of adjuvant chemotherapy was not 
significantly associated with breast reconstruction in 
our sample. Studies have reported conflicting data on 
the role of chemotherapy in breast reconstruction. Some 
studies have reported that receiving neoadjuvant or adju-
vant chemotherapy reduces the odds of receiving breast 
reconstruction (Alderman et al. 2009; Wolfswinkel et al. 
2013), while others report that it did not significantly 
affect the odds of receiving breast reconstruction (Elmore 
et  al. 2012; Enewold et  al. 2014; Maly et  al. 2009; Mor-
row et al. 2014). More work is needed to clarify the role 
of chemotherapy on the receipt of breast reconstruction. 
Similar to results found in other studies, we found that 
women who received adjuvant radiation therapy were 
less likely to receive breast reconstruction (Agarwal et al. 
2011; Alderman et al. 2003, 2009; Chen et al. 2009; Ene-
wold et al. 2014; Greenberg et al. 2008; Jagsi et al. 2014; 
Tseng et al. 2010). Patients who require radiation therapy 
are less likely to be referred to plastic surgeons for breast 
reconstruction reflecting concerns on the part of physi-
cians that radiation therapy will negatively impact the 
results of breast reconstruction (Greenberg et  al. 2008; 
Jagsi et al. 2014). There are currently no uniform guide-
lines to inform the use of breast reconstruction after 
radiation therapy and more research is needed to deter-
mine the effect of radiation therapy on breast reconstruc-
tion outcomes (Elmore et al. 2012; Jagsi et al. 2014).
Even when controlling for sociodemographic and clini-
cal factors, African American women in this sample were 
30  % less likely to receive breast reconstruction than 
their Caucasian counterparts. Although these results are 
consistent with previous studies (Agarwal et  al. 2011; 
Alderman et  al. 2003, 2006; Bradley et  al. 2012; Green-
berg et  al. 2008; Hershman et  al. 2012; Jackson et  al. 
2008; Joslyn 2005; Katz et  al. 2005; Kruper et  al. 2011a, 
b, 2013; Lang et al. 2013; Mahmoudi et al. 2015; Morrow 
et al. 2001, 2014; Offodile et al. 2015; Reuben et al. 2009; 
Rosson et al. 2008; Shippee et al. 2014; Sisco et al. 2012; 
Tseng et  al. 2004, 2010; Yang et  al. 2013a, b), they bol-
ster previous work on the topic by virtue of the relatively 
high percentage (20  %) of African American women in 
the sample. Yet our results are contrary to other studies 
that report no significant contribution of race on breast 
cancer rates, despite trends towards African Americans 
having lesser odds of breast reconstruction (Alderman 
et al. 2009; Chen et al. 2009; Christian et al. 2006; Elmore 
et al. 2012; Enewold et al. 2014; Iskandar et al. 2015; Kru-
per et  al. 2011b; Maly et  al. 2009; Polednak 1999, 2001; 
Sisco et al. 2012; Wolfswinkel et al. 2013). To our knowl-
edge, only one study has reported that African American 
women were significantly more likely to receive breast 
reconstruction than Caucasian women (Giladi et  al. 
2015). This may have been due to the fact that this study 
focused on a Medicaid population, with an overall low 
Table 2 Breast reconstruction rate and  type of  breast 
reconstructive surgery of  women treated with  mastec-
tomy for  breast cancer at  the Siteman Cancer Center 
from 2000 to 2012
NOS not otherwise specified
Variable Frequency % N
Received breast reconstruction
 Yes 2227 54 4152
 No 1925 46
Type of breast reconstruction
 Tissue expander/implant 990 52 1938
 Autologous flap 144 7
 Autologous flap and tissue expander/
implant
32 2
 Reduction mammoplasty 3 0.2
 Scar revision (Y-plasty) 9 0.5
 Reconstruction NOS 760 39
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income. Studies from NCI-CCCs have also produced 
conflicting results on the role of race on the receipt of 
breast reconstruction. Race did not significantly affect 
the odds of receiving breast reconstruction in two stud-
ies (Christian et al. 2006; Elmore et al. 2012), while Tseng 
et  al. (2004) found that African American women were 
66 % less likely to receive breast reconstruction compared 
to Caucasian women. The reasons for variations on the 
role of race on the receipt of breast reconstruction are 
unclear but may reflect differences in study populations, 
geographic location, use of different socioeconomic vari-
ables, or limited range of patient-related factors (Chris-
tian et  al. 2006; Wolfswinkel et  al. 2013). The results of 
this and previous studies raise the need for more research 
to examine racial/ethnic disparities in breast reconstruc-
tion across various types of healthcare institutions.
Limitations
This study has several limitations. It is focused on a sin-
gle comprehensive cancer center which limits its gener-
alizability to other healthcare institutions or geographical 
locations. Age, race, and insurance status were the only 
sociodemographic variables in the BJH Cancer Regis-
try. Therefore, we were unable to fully examine the role 
of socioeconomic status on breast reconstruction in our 
analysis and used insurance status as a proxy for socioeco-
nomic status. The Registry lacked information about other 
determinants of breast reconstruction such as marital 
status (Agarwal et al. 2011; Chen et al. 2009; Elmore et al. 
2012; Hershman et al. 2012; Joslyn 2005) and comorbidi-
ties (Chen et al. 2009; Hershman et al. 2012; Reuben et al. 
2009; Yang et  al. 2013a), including diabetes (Preminger 
et al. 2012), and obesity (Chen et al. 2009; Christian et al. 
2006; Greenberg et al. 2008; Preminger et al. 2012; Wolf-
swinkel et  al. 2013). The strengths of this study included 
the ability to use a large administrative database to quantify 
the rate and determinants of breast reconstruction after 
mastectomy in a NCI-CCC. The large sample of African 
American and Caucasian women allowed for multivariable 
regression analysis that incorporated sociodemographic 
and clinical determinants of breast reconstruction.
Conclusion
We found that Siteman Cancer Center had a relatively 
high breast reconstruction rate between 2000 and 2012. 
After adjusting for sociodemographic and clinical fac-
tors, women who were over the age of 55, had public 
insurance, were treated with unilateral mastectomy, or 
received adjuvant radiation therapy were significantly 
less likely to receive breast reconstruction. These findings 
mirror many of the most common predictors of breast 
reconstruction previously reported (Brennan and Spill-
ane 2013; Platt et al. 2011; Wilkins and Alderman 2004) 
and extend the findings of previous studies at Siteman 
Cancer Center (Connors et al. 2014; Elmore et al. 2012; 
Sharma et al. 2015) with a larger sample size. Of particu-
lar interest was that African American women were 30 % 
less likely to receive breast reconstruction at this NCI-
CCC. The presence of racial disparities in specialized 
tertiary healthcare institutions suggests that factors out-
side of access and quality of care may play a role in breast 
reconstruction disparities. These breast reconstruction 
disparities have also be reported in Asian, Latina, and 
Middle Eastern women (Agarwal et  al. 2011; Alderman 
et  al. 2003, 2009; Hershman et  al. 2012; Iskandar et  al. 
2015; Katz et  al. 2005; Kruper et  al. 2011a, b; Kruper 
et al. 2013; Lang et al. 2013; Mahmoudi et al. 2015; Maly 
et al. 2009; Offodile et al. 2015; Onega et al. 2014; Ship-
pee et al. 2014; Tseng et al. 2004, 2010; Yang et al. 2013a, 
2013b). It is therefore imperative to further examine and 
Table 3 Multivariable logistic regression of  breast recon-
struction in  women treated with  mastectomy for  breast 
cancer at  the Siteman Cancer Center from  2000 to  2012 
(N = 2809)
DCIS ductal carcinoma in situ, PR progesterone receptor
* Statistically significant variable
a Private insurance included: managed care, HMO, PPO, TRICARE, fee for service
b Public insurance included: Medicaid, Medicare, Veterans’ Affairs, Indian Health 
Service
Variable aOR 95 % CI p value
Age*
 <55 1.00 – –
 ≥55 0.35 0.29–0.42 <0.01
Race*
 Caucasian 1.00 – –
 African American 0.70 0.56–0.87 <0.01
Insurance*
 Privatea 1.00 – –
 Publicb 0.45 0.38–0.54 <0.01
Tumor stage*
 Stage 0/DCIS–2 1.00 – –
 Stage 3–4 0.60 0.47–0.76 <0.01
PR status
 Positive 1.00 – –
 Negative 0.87 0.73–1.03 0.12
Laterality of mastectomy*
 Bilateral 1.00 – –
 Unilateral 0.37 0.30–0.46 <0.01
Receipt of adjuvant chemotherapy
 No 1.00 – –
 Yes 1.06 0.87–1.30 0.55
Receipt of adjuvant radiation therapy*
 No 1.00 – –
 Yes 0.72 0.59–0.89 <0.01
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address the racial/ethnic disparities in breast recon-
struction. Although not considered in this study, patient 
involvement in decision-making and personal preference 
may play important roles in breast reconstruction dispar-
ities (Greenberg et al. 2008). Few studies focus on these 
topics among minority women (Rubin et al. 2013). Future 
research is needed to further delineate the determinants 
of breast reconstruction disparities across a variety of 
healthcare institutions, focusing on the role of decision-
making and personal preference in minority women. 
Only then can we develop multilevel interventions to 
ensure every breast cancer patient has equitable access to 
breast reconstruction and the improved quality of life it 
offers to breast cancer survivors.
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